In the race to improve speed and efficiency in drug development, clinical research studies have grown dramatically in the last decade in both numbers and complexity.
Adaptive design, multiple cohorts, randomisation, and detailed dosing instructions have been driving factors in this increase as sponsors are looking to achieve more endpoints within a single protocol. As companies continue to collect higher volumes of data in an effort to shorten the duration and number of trials required for submission, it becomes increasingly difficult for researchers to manage this information. This means the toolsets used to conduct studies are being relied upon more heavily.
For more information, click here